Mesa Laboratories, Inc.: updates and filings

MLABNASDAQIndustrials · Industrial Instruments For Measurement, Display, and Control

Price

$134.60

November 17, 2026Market cap $744M

What Ploutos Investor adds for Mesa Laboratories

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from FY2011
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 79 daysAround Feb 5, 2027 · for Q3 2027

last Nov 9, 2026next Feb 5, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Jun 3, 2026 latest annualNov 9, 2026 latest quarterly
  • Nov 9, 2026Results of operations
    Form8-K
  • Nov 9, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 13, 2026Restructuring costs, Regulation FD disclosure
    Form8-K
  • Oct 9, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Sep 8, 2026Shareholder vote
    Form8-K
  • Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 10, 2026Results of operations
    Form8-K
  • Jul 30, 2026Material event
    Form8-K
  • Jul 22, 2026Annual meeting proxy statement
    FormDEF 14A
  • Jul 7, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jun 15, 2026Officer or director change
    Form8-K
  • Jun 3, 2026Shares registered for employees
    FormS-8
  • Jun 3, 2026Annual reportfor the period to Mar 31, 2026
    Form10-K
  • May 27, 2026Results of operations
    Form8-K
  • Apr 15, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 23, 2026Officer or director change
    Form8-K
  • Mar 13, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Mar 9, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Feb 3, 2026Quarterly reportfor the period to Dec 31, 2025
    Form10-Q
  • Feb 3, 2026Results of operations
    Form8-K
  • Nov 6, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q
  • Nov 6, 2025Results of operations
    Form8-K
  • Oct 31, 2025Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 11, 1995.

The full analysis

What do Mesa Laboratories's filings show?

The filings are where every one of Mesa Laboratories's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.